Search Results 261-270 of 2456 for 谷歌日本搜索引入口咨询邮箱：lgooxc@hotmail.com
Special Request: We are collecting information to ensure shipping changes are communicated to the appropriate individual(s). Please send an e-mail to ...
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
The purpose of this study is to evaluate the effectiveness and safety of rivaroxaban compared with placebo in the prevention of symptomatic venous ...
All applications to use CCaTS facilities — the Clinical Research and Trials Unit (CRTU), Translational Technology Cores (TTCs), and Specialized Phenotyping ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This randomized, placebo-controlled, double-blind, parallel-arm study will evaluate the safety and tolerability of at least two dose levels of intravenous (IV) ...
Mayo Clinic offers healthcare professionals genome informed clinical recommendations related to the Electronic Medical Records and GEnomics (eMERGE) Network ...
The purpose of this study is to addressthe need to understand the natural heterogeneity of post-TBI longitudinal change, characterize at-risk groups, and ...
... Google Health's experts in applying AI to medical imaging. In this first stage of the initiative, Mayo Clinic and Google Health teams will use de-identified ...
The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.